DiaGyn Israeli Company

DiaGyn is developing a wide range of solutions targeting unmet needs in the area of womens health, integrating drug development and molecular genomics with personalized therapeutic approaches. The company is focused on addressing BRCA1/2 mutations in ovarian and breast cancer using a treatment strategy based on nanoparticle technology.